Qiagen (QGEN) News Today $41.27 -0.82 (-1.95%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Impax Asset Management Group plc Buys Shares of 180,729 Qiagen (NYSE:QGEN)Impax Asset Management Group plc purchased a new stake in Qiagen (NYSE:QGEN - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 180,729 shares of the company's stock, valued at approximately $8,236,000. ImpaNovember 16 at 6:36 AM | marketbeat.comQiagen enters three-year partnership with McGill UniversityNovember 14 at 10:34 AM | markets.businessinsider.comWhat is William Blair's Estimate for Qiagen FY2024 Earnings?November 14 at 1:29 AM | americanbankingnews.comVictory Capital Management Inc. Purchases 991,325 Shares of Qiagen (NYSE:QGEN)Victory Capital Management Inc. lifted its position in shares of Qiagen (NYSE:QGEN - Free Report) by 62.6% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,574,705 shares of the company's stock after buyinNovember 13 at 7:18 AM | marketbeat.comWilliam Blair Brokers Increase Earnings Estimates for QiagenQiagen (NYSE:QGEN - Free Report) - Research analysts at William Blair increased their FY2024 EPS estimates for shares of Qiagen in a research note issued on Monday, November 11th. William Blair analyst A. Brackmann now anticipates that the company will earn $2.17 per share for the year, up from tNovember 13 at 6:04 AM | marketbeat.comCrossmark Global Holdings Inc. Decreases Position in Qiagen (NYSE:QGEN)Crossmark Global Holdings Inc. cut its position in Qiagen (NYSE:QGEN - Free Report) by 17.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 56,775 shares of the company's stock after selling 12,133 shares during the period. Crossmark Global Holdings Inc.'sNovember 13 at 4:26 AM | marketbeat.comUBS Remains a Hold on Qiagen (QGEN)November 13 at 12:00 AM | markets.businessinsider.comQiagen’s Strong Performance and Strategic Initiatives Justify Buy RatingNovember 11, 2024 | markets.businessinsider.comQiagen’s Financial Growth and Rising Debt in Q3 2024November 10, 2024 | finance.yahoo.comQiagen’s Solid Performance with Potential Upside Amid Mixed SignalsNovember 9, 2024 | markets.businessinsider.comQiagen (QGEN) Receives a Hold from Stifel NicolausNovember 9, 2024 | markets.businessinsider.comQiagen reports Q3 adjusted EPS 57c, consensus 54cNovember 8, 2024 | markets.businessinsider.comQiagen NV (QGEN) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic AdvancementsNovember 8, 2024 | finance.yahoo.comQiagen N.V. (QGEN) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Qiagen (QGEN), NewAmsterdam Pharma Company (NAMS) and Praxis Precision Medicines (PRAX)November 7, 2024 | markets.businessinsider.comQiagen (NYSE:QGEN) Shares Sold by Van ECK Associates CorpVan ECK Associates Corp reduced its stake in Qiagen (NYSE:QGEN - Free Report) by 15.2% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 185,221 shares of the company's stock after selling 33,210November 7, 2024 | marketbeat.comQIAGEN delivers solid Q3 2024 growth ahead of outlook, increases full-year 2024 adjusted EPS outlookNovember 6, 2024 | markets.businessinsider.comDiagnostics firm Qiagen reports rise in third-quarter revenueNovember 6, 2024 | reuters.comQiagen NV (QGEN) Q3 2024: Everything You Need to Know Ahead of EarningsNovember 6, 2024 | finance.yahoo.comQiagen NV (QGEN) Q3 2024 Earnings Report Preview: What to ExpectNovember 5, 2024 | finance.yahoo.comQiagen's QIAstat-Dx Meningitis/encephalitis Panel Gets FDA Clearance For Emergency DiagnosticsNovember 4, 2024 | markets.businessinsider.comQIAGEN receives FDA clearance of QIAstat-Dx meningitis/encephalitis panel to support emergency diagnosticsNovember 4, 2024 | globenewswire.comForsta AP Fonden Sells 18,586 Shares of Qiagen (NYSE:QGEN)Forsta AP Fonden trimmed its holdings in shares of Qiagen (NYSE:QGEN - Free Report) by 64.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 10,146 shares of the company's stock afterOctober 31, 2024 | marketbeat.comQiagen (QGEN) Set to Announce Earnings on WednesdayQiagen (NYSE:QGEN) will be releasing earnings after the market closes on Wednesday, November 6, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634522)October 30, 2024 | marketbeat.comRaymond James & Associates Sells 343,714 Shares of Qiagen (NYSE:QGEN)Raymond James & Associates trimmed its stake in Qiagen (NYSE:QGEN - Free Report) by 63.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 198,739 shares of the company's stock after selling 343,714 shares durinOctober 30, 2024 | marketbeat.comQiagen announces FDA clearance of QIAstat-Dx Respiratory Panel Mini testOctober 29, 2024 | markets.businessinsider.comQIAGEN receives FDA clearance for QIAstat-Dx mini panel to improve precision in outpatient respiratory treatmentOctober 29, 2024 | globenewswire.comQiagen (NYSE:QGEN) Given Average Rating of "Moderate Buy" by AnalystsQiagen (NYSE:QGEN - Get Free Report) has earned an average recommendation of "Moderate Buy" from the eleven ratings firms that are presently covering the firm, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating on the company. TheOctober 26, 2024 | marketbeat.comPrentiss Smith & Co. Inc. Takes $3.92 Million Position in Qiagen (NYSE:QGEN)Prentiss Smith & Co. Inc. purchased a new position in shares of Qiagen (NYSE:QGEN - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 85,986 shares of the company's stock,October 21, 2024 | marketbeat.comHsbc Global Res Upgrades Qiagen (NYSE:QGEN) to "Hold"Hsbc Global Res upgraded shares of Qiagen to a "hold" rating in a research note on Thursday.October 18, 2024 | marketbeat.comQiagen N.V. (NYSE:QGEN) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future?October 18, 2024 | finance.yahoo.comHSBC Downgrades Qiagen N.V. (QGEN)October 18, 2024 | msn.comQiagen (NYSE:QGEN) Rating Lowered to Hold at HSBCHSBC lowered Qiagen from a "buy" rating to a "hold" rating and set a $49.00 target price on the stock. in a report on Thursday.October 17, 2024 | marketbeat.comCubist Systematic Strategies LLC Has $196,000 Stock Holdings in Qiagen (NYSE:QGEN)Cubist Systematic Strategies LLC lessened its stake in Qiagen (NYSE:QGEN - Free Report) by 92.5% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 4,763 shares of the company's stock after selling 59,013 shares during the quarter. Cubist SysOctober 15, 2024 | marketbeat.comExchange Traded Concepts LLC Has $12.57 Million Stock Holdings in Qiagen (NYSE:QGEN)Exchange Traded Concepts LLC trimmed its position in Qiagen (NYSE:QGEN - Free Report) by 18.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 275,765 shares of the company's stock after selling 62,505 shOctober 13, 2024 | marketbeat.comQIAGEN N.V.: QIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applicationsOctober 12, 2024 | finanznachrichten.deQIAGEN expands automated liquid biopsy portfolio to enhance oncology, prenatal care and organ transplant applicationsOctober 10, 2024 | globenewswire.comQIAGEN N.V. to release results for Q3 2024 and hold webcastOctober 10, 2024 | globenewswire.comHandelsbanken Fonder AB Has $3.34 Million Stock Position in Qiagen (NYSE:QGEN)Handelsbanken Fonder AB raised its holdings in shares of Qiagen (NYSE:QGEN - Free Report) by 37.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 73,304 shares of the company's stock after acquiring an additioOctober 9, 2024 | marketbeat.comGlobal TB Summit 2024: QIAGEN leads the charge as tuberculosis reemerges as a leading infectious killerOctober 7, 2024 | globenewswire.comAQR Capital Management LLC Has $3.36 Million Stock Holdings in Qiagen (NYSE:QGEN)AQR Capital Management LLC increased its position in shares of Qiagen (NYSE:QGEN - Free Report) by 20.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 81,748 shares of the company's stock after acquiring an additioOctober 7, 2024 | marketbeat.comQiagen (NYSE:QGEN) Shares Sold by SG Americas Securities LLCSG Americas Securities LLC trimmed its position in Qiagen (NYSE:QGEN - Free Report) by 6.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 464,202 shares of the company's stock after sellingOctober 5, 2024 | marketbeat.comQIAGEN N.V.: QIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncologyOctober 1, 2024 | finanznachrichten.deSycomore Asset Management Purchases Shares of 101,488 Qiagen (NYSE:QGEN)Sycomore Asset Management acquired a new position in Qiagen (NYSE:QGEN - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 101,488 shares of the company's stock, valued at approximately $4,425,000. A number of other hOctober 1, 2024 | marketbeat.comQiagen (NYSE:QGEN) Given Average Rating of "Moderate Buy" by BrokeragesQiagen (NYSE:QGEN - Get Free Report) has received a consensus rating of "Moderate Buy" from the nine research firms that are presently covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the compOctober 1, 2024 | marketbeat.comQIAGEN launches QIAcuityDx digital PCR system for clinical testing in oncologySeptember 30, 2024 | globenewswire.comSusquehanna Fundamental Investments LLC Has $3.19 Million Stock Position in Qiagen (NYSE:QGEN)Susquehanna Fundamental Investments LLC lifted its stake in Qiagen (NYSE:QGEN - Free Report) by 235.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 77,557 shares of the company's stock afterSeptember 30, 2024 | marketbeat.comThose who invested in Qiagen (NYSE:QGEN) five years ago are up 41%September 29, 2024 | uk.finance.yahoo.comMarshall Wace LLP Sells 207,630 Shares of Qiagen (NYSE:QGEN)Marshall Wace LLP reduced its position in Qiagen (NYSE:QGEN - Free Report) by 44.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 261,393 shares of the company's stock after selling 207,630 shares during the period. Marshall WaceSeptember 29, 2024 | marketbeat.comQiagen (NYSE:QGEN) Shares Acquired by Susquehanna International Securities Ltd.Susquehanna International Securities Ltd. raised its holdings in shares of Qiagen (NYSE:QGEN - Free Report) by 9.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 146,337 shares of the company's stock aftSeptember 28, 2024 | marketbeat.com Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too? Click Here For Your Free Guide QGEN Media Mentions By Week QGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. QGEN News Sentiment▼0.770.55▲Average Medical News Sentiment QGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. QGEN Articles This Week▼125▲QGEN Articles Average Week Get Qiagen News Delivered to You Automatically Sign up to receive the latest news and ratings for QGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BNTX News TEVA News BGNE News VTRS News MRNA News GMAB News SMMT News RDY News PCVX News CTLT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:QGEN) was last updated on 11/16/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored🗓️ My First LIVE Event in 5 Years!Give us 60 minutes and we’ll show you how we’ve compressed 15 years of stock market gains into one day.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Qiagen Please log in to your account or sign up in order to add this asset to your watchlist. Share Qiagen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.